4 - Using Business Intelligence Data Analytics to Improve Scheduling of Urgent and Non-Urgent Gastroenterology Clinic and Endoscopies in a Large Safety-Net Hospital
Location: Ballroom B
Presenting Author: Jared Gloria, MD – Emory University School of Medicine, J. Willis Hurst Internal Medicine Residency
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 23rd
8:40 AM – 8:50 AM PT
5 - GLP-1 Agonists and Their Efficacy for Weight Loss: Unraveling the Best Option Through Network Meta-Analysis
9 - Biologic and Small Molecule Therapies Are Not Associated with Increased Major Adverse Cardiovascular Events (MACE) in IBD: A Propensity Matched Cohort Study
10 - Association Between Cold Snare Polypectomy Rate (CSPR) and Existing Endoscopist Quality Metrics: A New Frontier in Colonoscopy Quality Measurement?
Paper Session Moderator: Ayse Aytaman, MD, FACG – VA NY Harbor Healthcare System Brooklyn
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 23rd
2:15 PM – 2:25 PM PT
11 - Prevalence of Colon Cancer in Patients Undergoing Colonoscopy with a Diverticulitis Indication Compared to a Screening Population
Location: Ballroom A
Presenting Author: Walker D. Redd, MD – University of North Carolina School of Medicine
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 23rd
2:15 PM – 2:25 PM PT
15 - Impact of Pharmacologic Treatment for Alcohol Use Disorder on Mortality in Patients with Alcohol-Associated Liver Disease: Analysis From a United States Insurance Claims Database
17 - Seladelpar Treatment Resulted in Correlated Decreases in Serum IL-31 and Pruritus in Patients with Primary Biliary Cholangitis (PBC): Post-Hoc Results from the Phase 3 Randomized, Placebo-Controlled ENHANCE Study
32 - Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn’s Disease Patients with Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results from the POWER Study
33 - Symptomatic Improvement Observed Within 2 Days of Etrasimod Induction Therapy: Results from ELEVATE UC 52 and ELEVATE UC 12 Studies in Patients with Ulcerative Colitis
25 - Efficacy and Safety of the Selective Sphingosine 1-Phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis: Primary Results from the Phase 2 VOYAGE Study
34 - Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results from the Phase 3 QUASAR Induction Study
35 - Risankizumab Induction Therapy in Patients WIth Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
39 - Plant-Based Meals Generate Lower Ammonia and Have a Unique Metabolomic Signature Compared to Meat-Based Meals Despite Similar Baseline Microbiome in Patients with Cirrhosis: A Randomized Clinical Trial
48 - Implementation of a Digital Cancer Risk Assessment Tool and Genetic Testing Program in Gastroenterology Practices Throughout the US Identifies Inherited Cancer Susceptibility Syndromes in 15.6% of Patients Tested
49 - Sessile Serrated Lesion Detection Rate in Individuals with Positive Fecal Immunohistochemical Test Undergoing Colonoscopy: Results from a Large Nationwide Veterans Affairs Database
50 - Use of Mechanical Enhanced Colonoscopy to Improve Polyp Detection During Colorectal Cancer Screening: A Preliminary Results of Real-World Healthcare Database Analysis
51 - Lower Incidence of Gastrointestinal Cancers in Sodium Glucose Co-Transporter-2 Inhibitor-Treated Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study in the United States
43 - The Complex Relationship Between Pain, Mental Health, and Quality-Of-Life in Cirrhosis Patients Awaiting Liver Transplant
Location: Ballroom A
Presenting Author: Jessica B. Rubin, MD, MPH – University of California San Francisco and San Francisco VA Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 24th
3:15 PM – 3:25 PM PT
52 - Interventions to Improve the Quality of Screening-Related Colonoscopy: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
54 - Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening: A Prospective Clinical Validation Study (BLUE-C) (Late-Breaking Abstract)
Location: Ballroom B
Late Breaking Abstract Presenter: Thomas F. Imperiale, MD – Indiana University Medical Center
Paper Session Moderator: Asmeen Bhatt, MD, PhD – University of Texas Health Science Center at Houston
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 25th
8:30 AM – 8:40 AM PT
55 - Similar Efficacy of a Novel Bipolar Radiofrequency Ablation Knife to Monopolar Current Knife in Endoscopic Submucosal Dissection of Colonic Lesions: A Non-Inferiority Randomized Trial
65 - Outcomes of Anti-Obesity Glucagon-Like Peptide 1 Agonists vs Revisional Endoscopic Sleeve Gastroplasty for Weight Regain After Laparoscopic Sleeve Gastrectomy: A Case-Control Real World Experience
Location: Ballroom B
Presenting Author: Firas Bahdi, MD (he/him/his) – David Geffen School of Medicine at University of California Los Angeles
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 25th
8:40 AM – 8:50 AM PT
56 - Outcomes from Hemorrhoidal Artery Embolization in a Multidisciplinary Outpatient Interventional Center: A Review of 211 Patients
67 - Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients
58 - Successful EUS-Guided Pancreatic Cyst Chemoablation Safely Allows Reduction in the Intensity of Post Treatment Radiographic Surveillance: Long-Term Follow-Up of Randomized Prospective Data
Location: Ballroom A
Presenting Author: Wes Heinle, MPH – Penn State Health Milton S. Hershey Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 25th
9:00 AM – 9:10 AM PT
68 - Non-Invasive Vagal Nerve Stimulation Reduces Nausea Rescue Medication in Patients With Gastroparesis and Related Disorders, With Additional Benefits on Multiple Other Associated Symptoms
59 - Prospective Evaluation of Procedural Factors Related to False Negative Fluorescence In-Situ Hybridization (FISH) in Patients with Extrahepatic Cholangiocarcinoma
69 - Efficacy of Guselkumab in Patients With Moderately to Severely Active Crohn’s Disease Not in Clinical Response at Week 12: Results From the GALAXI 1 Study
70 - Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment: Interim Results From the LUCENT-3 Open-Label Extension Study
71 - Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naïve Patients With Complex Crohn’s Disease: Results from the EVOLVE Expansion Study
63 - Treatment of Exocrine Pancreatic Insufficiency in Patients with Chronic/Recurrent Acute Pancreatitis Improves Treatment Satisfaction and Decreases Healthcare Utilization: Interim Findings from the PACT-CP Registry
73 - Dupilumab Improves Histologic and Endoscopic Aspects of Eosinophilic Esophagitis (EoE), as Well as Rate of Weight Gain, in Children Aged 1 to <12 years: 52-week Results From the Phase 3 EoE KIDS Trial (Late-Breaking Abstract)